Scientific publications
Scientific publications of the Veneto Tumour Registry
Epidemiology and public health response in early phase of COVID-19 pandemic, Veneto Region, Italy, 21 February to 2 April 2020
Russo F, Pitter G, Da Re F, Tonon M, Avossa F, Bellio S, Fedeli U, Gubian L, Monetti D, Saia M, Zanella F, Zorzi M, Narne E, Mantoan D. Euro Surveill. 2020 Nov;25(47):2000548. doi: 10.2807/1560-7917.ES.2020.25.47.2000548. Abstract BackgroundVeneto was one of the Italian regions hit hardest by the early phase of the coronavirus disease (COVID-19) pandemic.AimThis paper describes the public health response and epidemiology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in the Veneto Region from 21 February to 2 April 2020.MethodsInformation on the public health...
Use of an Artificial Neural Network to Identify Patient Clusters in a Large Cohort of Patients with Melanoma by Simultaneous Analysis of Costs and Clinical Characteristics
Damiani G, Buja A, Grossi E, Rivera M, De Polo A, De Luca G, Zorzi M, Vecchiato A, Del Fiore P, Saia M, Baldo V, Rugge M, Rossi CR, Damiani G. Acta Derm Venereol. 2020 Nov 18;100(18):adv00323. doi: 10.2340/00015555-3680. Pubmed https://pubmed.ncbi.nlm.nih.gov/33135769/
Determinants of p16/Ki-67 adequacy and positivity in HPV-positive women from a screening population
Benevolo M, Mancuso P, Allia E, Gustinucci D, Bulletti S, Cesarini E, Carozzi FM, Confortini M, Bisanzi S, Rubino T, Rollo F, Marchi N, Farruggio A, Pusiol T, Venturelli F, Giorgi Rossi P; New Technologies for Cervical Cancer 2 (NTCC2) Working Group. Cancer Cytopathol. 2020 Nov 3. doi: 10.1002/cncy.22385. Online ahead of print. Abstract Background: The objective of this study was to describe the determinants of adequacy and positivity of the p16/Ki-67 assay in a human papillomavirus (HPV)-positive screening population enrolled within the New Technologies for Cervical Cancer 2 (NTCC2) study....
Cancer prevalence by phase of care: an indicator for assessing health service needs
Gigli A, Francisci S, Guzzinati S, Hall A, Hachey M, Scoppa S, Mariotto A. Tumori. 2020 Oct 23:300891620961839. doi: 10.1177/0300891620961839. Online ahead of print. Abstract Introduction: Cancer prevalence (people alive on a certain date in a population who previously had a cancer diagnosis) is expected to increase in the United States and Europe due to improvements in survival and population aging. Examination of prevalence by phase of care allows us to identify subgroups of patients according to their care trajectories, thus allowing us to improve health care planning, resource...
Cancer cure for 32 cancer types: results from the EUROCARE-5 study
Dal Maso L, Panato C, Tavilla A, Guzzinati S, Serraino D, Mallone S, Botta L, Boussari O, Capocaccia R, Colonna M, Crocetti E, Dumas A, Dyba T, Franceschi S, Gatta G, Gigli A, Giusti F, Jooste V, Minicozzi P, Neamtiu L, Romain G, Zorzi M, De Angelis R, Francisci S; EUROCARE-5 Working Group. Int J Epidemiol. 2020 Sep 28:dyaa128. doi: 10.1093/ije/dyaa128. Online ahead of print. Abstract Background: Few studies have estimated the probability of being cured for cancer patients. This study aims to estimate population-based indicators of cancer cure in Europe by type, sex, age and period. Methods:...
Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients
Trifirò G, Massari M, Da Cas R, Menniti Ippolito F, Sultana J, Crisafulli S, Giorgi Rossi P, Marino M, Zorzi M, Bovo E, Leoni O, Ludergnani M, Spila Alegiani S; ITA-COVID-19: RAAS inhibitor group. [published online ahead of print, 2020 Aug 27]. Drug Saf. 2020. doi: 10.1007/s40264-020-00994-5 Abstract Introduction: The epidemic due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been spreading globally, raising increasing concerns. There are several controversial hypotheses on the potentially harmful or beneficial effects of antihypertensive drugs acting on the...
Impact of Rhabdomyosarcoma Treatment Modalities by Age in a Population-Based Setting
Ferrari A, Bernasconi A, Bergamaschi L, Botta L, Andreano A, Castaing M, Rugge M, Bisogno G, Falcini F, Sacerdote C, Tagliabue G, Michiara M, Cirilli C, Barchielli A, Filiberti RA, Vitale MF, Tumino R, Stracci F, Chiaravalli S, Casanova M, Gasparini P, Milano GM, Gatta G, Trama A. J Adolesc Young Adult Oncol. 2020 Jul 30. doi: 10.1089/jayao.2020.0043. Online ahead of print. Abstract Purpose: Rhabdomyosarcoma (RMS) has a worse prognosis in adults than in children, but there is evidence of a better outcome in the former if treated using a pediatric-like approach. This study describes treatment...
Colonoscopy related adverse events and mortality in an Italian organized colorectal cancer screening program
Benazzato L, Zorzi M, Antonelli G, Guzzinati S, Hassan C, Fantin A. [published online ahead of print, 2020 Jul 28]. Endoscopy. 2020;10.1055/a-1228-9225. doi:10.1055/a-1228-9225 Abstract Background and Aims Post-colonoscopy adverse events (AE) are a key quality indicator in population-based colorectal cancer screening programs, affecting safety and costs. Aim of this study was to assess colonoscopy-related AE and mortality in a screening setting. Methods We retrieved data from a cohort of patients undergoing colonoscopy within a screening program (Faecal Immunochemical Test every 2 years, 50...
Main topics
Scientific publications
Scientific publications of the Veneto Tumour Registry
Monographs
Reports by tumour site and monographs.
Congress and conference
Discover all the oral publications and posters.